Product overview
Type
Diphtheria-Tetanus-Pertussis (whole cell)
Commercial Name
Diphtheria-Tetanus-Pertussis Vaccine Adsorbed
Manufacturer
Serum Institute of India Pvt. Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
20
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
24 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 14
Secondary Packaging
carton of 25 vials (500 doses) [Dimensions 13.3x13.3x6.0 cm]
Tertiary Packaging
Box of 24 cartons of 25 vials (600 vials/12000 doses) [Dimensions 60x48x41 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.005%
Cold Chain Volume
2.122 cm3/dose (in secondary packaging)
Attachments
